These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 27593183

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Preparation, characterization and in vivo evaluation of amorphous tacrolimus nanosuspensions produced using CO2-assisted in situ nanoamorphization method.
    Wang Y, Han X, Wang J, Wang Y.
    Int J Pharm; 2016 May 30; 505(1-2):35-41. PubMed ID: 27034003
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Fabrication of carvedilol nanosuspensions through the anti-solvent precipitation-ultrasonication method for the improvement of dissolution rate and oral bioavailability.
    Liu D, Xu H, Tian B, Yuan K, Pan H, Ma S, Yang X, Pan W.
    AAPS PharmSciTech; 2012 Mar 30; 13(1):295-304. PubMed ID: 22246736
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Development of an amorphous nanosuspension by sonoprecipitation-formulation and process optimization using design of experiment methodology.
    Gajera BY, Shah DA, Dave RH.
    Int J Pharm; 2019 Mar 25; 559():348-359. PubMed ID: 30721724
    [Abstract] [Full Text] [Related]

  • 8. Effects of stabilizing agents on the development of myricetin nanosuspension and its characterization: an in vitro and in vivo evaluation.
    Hong C, Dang Y, Lin G, Yao Y, Li G, Ji G, Shen H, Xie Y.
    Int J Pharm; 2014 Dec 30; 477(1-2):251-60. PubMed ID: 25445518
    [Abstract] [Full Text] [Related]

  • 9. Nanoprecipitation with sonication for enhancement of oral bioavailability of furosemide.
    Sahu BP, Das MK.
    Acta Pol Pharm; 2014 Dec 30; 71(1):129-37. PubMed ID: 24779201
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Preparation of azithromycin nanosuspensions by reactive precipitation method.
    Hou CD, Wang JX, Le Y, Zou HK, Zhao H.
    Drug Dev Ind Pharm; 2012 Jul 30; 38(7):848-54. PubMed ID: 22092042
    [Abstract] [Full Text] [Related]

  • 13. Diclofenac nanosuspensions: influence of preparation procedure and crystal form on drug dissolution behaviour.
    Lai F, Sinico C, Ennas G, Marongiu F, Marongiu G, Fadda AM.
    Int J Pharm; 2009 May 21; 373(1-2):124-32. PubMed ID: 19429297
    [Abstract] [Full Text] [Related]

  • 14. Honokiol nanosuspensions: preparation, increased oral bioavailability and dramatically enhanced biodistribution in the cardio-cerebro-vascular system.
    Han M, Yu X, Guo Y, Wang Y, Kuang H, Wang X.
    Colloids Surf B Biointerfaces; 2014 Apr 01; 116():114-20. PubMed ID: 24448177
    [Abstract] [Full Text] [Related]

  • 15. Cefdinir nanosuspension for improved oral bioavailability by media milling technique: formulation, characterization and in vitro-in vivo evaluations.
    Sawant KK, Patel MH, Patel K.
    Drug Dev Ind Pharm; 2016 Apr 01; 42(5):758-68. PubMed ID: 26548349
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Development and characterization of an orodispersible film containing drug nanoparticles.
    Shen BD, Shen CY, Yuan XD, Bai JX, Lv QY, Xu H, Dai L, Yu C, Han J, Yuan HL.
    Eur J Pharm Biopharm; 2013 Nov 01; 85(3 Pt B):1348-56. PubMed ID: 24103635
    [Abstract] [Full Text] [Related]

  • 18. [Preparation, characterization and dissolution characteristics of dragon's blood extract nanosuspensions].
    Wang LF, Chen XN, Li J, Tu PF, Wang JL.
    Zhongguo Zhong Yao Za Zhi; 2019 Jun 01; 44(11):2236-2243. PubMed ID: 31359648
    [Abstract] [Full Text] [Related]

  • 19. Preparation of ritonavir nanosuspensions by microfluidization using polymeric stabilizers: I. A Design of Experiment approach.
    Karakucuk A, Celebi N, Teksin ZS.
    Eur J Pharm Sci; 2016 Dec 01; 95():111-121. PubMed ID: 27181836
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.